Aquestive Therapeutics President and CEO Daniel Barber Reports Sale of $105,600 in Common Shares

Aquestive Therapeutics President, CEO and director Daniel Barber sold 25,000 shares of common stock on Oct. 15, 2026. The reported sale price was $4.224 per share. * Barber directly owned 627,317 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-012986), on October 16, 2026, and is solely responsible for the information contained therein. (C)